← Leaderboards
Richard R Barakat
Sloan-Kettering Institute For Cancer Res
$3,314,711
Attributed
$3,314,711
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $580.6K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$3,314,711 · 3
By mechanism
R01$2,837,711 · 1
P01$477,000 · 2
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Miguel-Angel Perales$7,415,804
- James W. Young$11,235,643
- Nai-Kong V Cheung$9,578,208
- David R Spriggs$13,987,182
- Arti Hurria$7,678,132
Others in their field
Top investigators on “Quality Of Life”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Gregory H Reaman · National Childhood Cancer Foundation$264,644,476
- David R. Weir · University Of Michigan At Ann Arbor$263,050,576
- Richard K. Wilson · Washington University$198,912,538
Research focus
Quality Of LifeGynecologicAnticancer ResearchEmotionalEventAreaDesignDiagnostic Neoplasm StagingDistressEarly IdentificationDiagnosisCancer SurgeryCancer SurvivorCancer TherapyDissectionCharacteristicsChemotherapyChronicBlood VesselsAdjuvant TherapyBody Mass IndexContinuance Of LifeCancer PatientEndometrial Carcinoma
Grant awards (9)
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and$574,604
R01 · FY2016 · CA · contact PI
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and$580,614
R01 · FY2015 · CA · contact PI
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and$558,986
R01 · FY2014 · CA · contact PI
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and$547,497
R01 · FY2013 · CA · contact PI
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and$576,010
R01 · FY2011 · CA · contact PI
Administrative$209,247
P01 · FY2005 · CA
CLINICAL TRIALS--CHEMOTHERAPY OF EPITHELIAL OVARIAN CANCER$0
P01 · FY2002 · CA
CLINICAL TRIALS--CHEMOTHERAPY OF EPITHELIAL OVARIAN CANCER$0
P01 · FY2001 · CA
CLINICAL TRIALS--CHEMOTHERAPY OF EPITHELIAL OVARIAN CANCER$267,753
P01 · FY2000 · CA